Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001600620-23-000005
Filing Date
2023-04-18
Accepted
2023-04-18 16:24:57
Documents
27

Document Format Files

Seq Description Document Type Size
1 DEF 14A auph-20230418.htm   iXBRL DEF 14A 1505254
6 auph-20230418_g1.jpg GRAPHIC 11010
7 auph-20230418_g10.jpg GRAPHIC 110000
8 auph-20230418_g11.jpg GRAPHIC 129145
9 auph-20230418_g12.jpg GRAPHIC 108654
10 auph-20230418_g13.jpg GRAPHIC 38273
11 auph-20230418_g2.jpg GRAPHIC 33931
12 auph-20230418_g3.jpg GRAPHIC 183904
13 auph-20230418_g4.jpg GRAPHIC 93004
14 auph-20230418_g5.jpg GRAPHIC 169706
15 auph-20230418_g6.jpg GRAPHIC 170621
16 auph-20230418_g7.jpg GRAPHIC 118815
17 auph-20230418_g8.jpg GRAPHIC 108244
18 auph-20230418_g9.jpg GRAPHIC 105660
  Complete submission text file 0001600620-23-000005.txt   5634750

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20230418.xsd EX-101.SCH 4536
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20230418_def.xml EX-101.DEF 6120
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20230418_lab.xml EX-101.LAB 9582
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20230418_pre.xml EX-101.PRE 5717
21 EXTRACTED XBRL INSTANCE DOCUMENT auph-20230418_htm.xml XML 145332
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 981231763 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36421 | Film No.: 23827147
SIC: 2834 Pharmaceutical Preparations